Western Blot – News and Features

Developed to detect DNA and proteins associated with tumour generation.

Syngene’s imaging system is used to identify proteins that impact the pathology of muscular dystrophy.

Deal strengthens AbD Serotec's position as primary source of reagents for studying the innate immune system.

Second contract awarded to company as part of NCI initiative to improve monoclonal antibody reagents for proteomics research.

Syngene’s imaging being used as fast and cost-effective system of assessing protein expression.

UK Cambridge Research Institute uses Dyversity to accelerate the pace of research on proteins and DNA associated with a variety of different cancers.

Syngene, a world-leading manufacturer of image analysis sol- utions, is pleased to announce its Dyversity multi-application image analyser is being used by scientists in The Cancer Research UK Cambridge Research Institute (CRI) at the University of Cambridge, one of Europe’s major cancer research hubs, to accelerate the pace of research on proteins and DNA associated with a variety of different cancers.

Precision Antibody™ has been selected as the antibody developer for a component of the National Cancer Institute (NCI)’s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.

SCRUM, Inc. and Alpha-Analytical to exclusively represent all Protein Forest products in their respective countries.

Syngene’s 2D gel imaging system helps to detect proteins associated with longer human life span.